The tech tool has been subject to criticism and controversy since being launched by the department five years ago.

MDAI READ THE FULL MDAI RESEARCH REPORT It has now been approximately seven months since Spectral AI, Inc. (NASDAQ:MDAI) announced its De Novo marketing application to the FDA for the DeepView device.

Hedgeye Capital Allocation ETF is a rules-based strategy rotating 140+ ETFs to target long-term growth and limit drawdowns to ...

For a project in Bangladesh, Prof. Mushfiq Mobarak and his team used machine-learning models applied to mobile phone records ...

NextCell Pharma AB ("NextCell" or the "Company") provides a strategic update on its focused market progression strategy, aimed at accelerating value creation by advancing ProTrans in adult patients, w ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

The study shows that personalized medicine demands new competences that extend beyond traditional medical training.

There is growing concern that AI-generated government decisions will reflect and intensify forms of discrimination and bias, ...

Opportunities include leveraging synthetic data, now over 50%, to enhance autonomous driving by filling long-tail scenarios. The full-process automated toolchain lowers costs and boosts efficiency, ...

OpenAI now uses behavioral signals to identify accounts likely belonging to minors and automatically apply content limits, ...

But two weeks in, I found that shopping second-hand isn’t the challenge it used to be. Physical vintage shopping is more ...